mephyton- phytonadione tablet
bausch health us llc - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 5 mg - mephyton is indicated for the treatment of adults with the following coagulation disorders which are due to faulty formation of factors ii, vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity. mephyton is contraindicated in patients with a history of a hypersensitivity reaction to phytonadione or inactive ingredients [see description (11)] . risk summary published studies with the use of phytonadione during pregnancy have not reported a clear association with phytonadione and adverse developmental outcomes [see data]. there are maternal and fetal risks associated with vitamin k deficiency during pregnancy [see clinical considerations]. animal reproduction studies have not been conducted with phytonadione. the estimated background risk for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinica
mephyton- phytonadione tablet
rebel distributors corp - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 5 mg - mephyton is indicated in the following coagulation disorders which are due to faulty formation of factors ii, vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity. mephyton tablets are indicated in: - anticoagulant-induced prothrombin deficiency caused by coumarin or indanedione derivatives; - hypoprothrombinemia secondary to antibacterial therapy; - hypoprothrombinemia secondary to administration of salicylates; - hypoprothrombinemia secondary to obstructive jaundice or biliary fistulas but only if bile salts are administered concurrently, since otherwise the oral vitamin k will not be absorbed. hypersensitivity to any component of this medication.
mephyton- phytonadione tablet
physicians total care, inc. - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 5 mg - mephyton is indicated in the following coagulation disorders which are due to faulty formation of factors ii,vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity. mephyton tablets are indicated in: hypersensitivity to any component of this medication.
mephyton- phytonadione tablet
carilion materials management - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 5 mg - mephyton is indicated in the following coagulation disorders which are due to faulty formation of factors ii,vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity. mephyton tablets are indicated in: hypersensitivity to any component of this medication.
mephyton- phytonadione tablet
a-s medication solutions - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - mephyton is indicated in the following coagulation disorders which are due to faulty formation of factors ii, vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity. mephyton tablets are indicated in: hypersensitivity to any component of this medication.
aquamephyton phytonadione injection emulsion
teligent pharma, inc. - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 2 mg in 1 ml
mephyton phytonadione tablet
cardinal health - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 5 mg
mephyton phytonadione tablet
kaiser foundation hospitals - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 5 mg
mephyton phytonadione tablet
avera mckennan hospital - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 5 mg
ambroton syrup
arpimed llc - ambroxol (ambroxol hydrochloride) - syrup - 15mg/5ml